0001140361-15-029318.txt : 20150731 0001140361-15-029318.hdr.sgml : 20150731 20150731145813 ACCESSION NUMBER: 0001140361-15-029318 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150731 DATE AS OF CHANGE: 20150731 EFFECTIVENESS DATE: 20150731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adheron Therapeutics, Inc. CENTRAL INDEX KEY: 0001649103 IRS NUMBER: 204870340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-244897 FILM NUMBER: 151019110 BUSINESS ADDRESS: STREET 1: MAIL BOXES PLUS, BOX 104 STREET 2: 2930 DOMINGO AVENUE CITY: BERKELEY STATE: CA ZIP: 94705 BUSINESS PHONE: 858-926-8155 MAIL ADDRESS: STREET 1: MAIL BOXES PLUS, BOX 104 STREET 2: 2930 DOMINGO AVENUE CITY: BERKELEY STATE: CA ZIP: 94705 D 1 primary_doc.xml X0707 D LIVE 0001649103 Adheron Therapeutics, Inc. MAIL BOXES PLUS, BOX 104 2930 DOMINGO AVENUE BERKELEY CA CALIFORNIA 94705 858-926-8155 DELAWARE None None Corporation true Hari Kumar MailBoxes Plus, Box 104 2930 Domingo Avenue Berkeley CA CALIFORNIA 94705 Executive Officer Director Chief Executive Officer. Bob Baltera 7916 Entrada De Luz East San Diego CA CALIFORNIA 92127 Director Executive Officer Executive Chairman. Doug Onsi c/o HealthCare Ventures LLC 47 Thorndike Street, B1-1 Cambridge MA MASSACHUSETTS 02141 Director Ron Laufer c/o Medlmmune Ventures, Inc. One Medlmmune Way Gaithersburg MD MARYLAND 20878 Director Isai Peimer c/o Medlmmune Ventures, Inc. One Medlmmune Way Gaithersburg MD MARYLAND 20878 Director Rajeev Dadoo 161 Washington Street Eight Tower Bridge, Suite 500 Conshohocken PA PENNSYLVANIA 19428 Director David Castaldi 11 Bellingham Road Chestnut Hill MA MASSACHUSETTS 02467 Director Chris Thomajan 233 Rutledge Road Belmont MA MASSACHUSETTS 02478 Executive Officer Chief Financial Officer. Pharmaceuticals Decline to Disclose 06b false 2015-07-17 false true true true true Convertible Promissory Notes, convertible into shares of common stock or preferred stock, as the case may be. Warrants are issuable immediately prior to an equity financing, exercisable for the same class of shares as sold in such equity financing. false 0 1500000 1500000 0 true 0 5 0 0 0 false Adheron Therapeutics, Inc. Hari Kumar Hari Kumar CEO 2015-07-31